期刊
JOURNAL OF INFECTIOUS DISEASES
卷 220, 期 -, 页码 S274-S278出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiz297
关键词
meningitis belt; multivalent meningococcal vaccines; epidemic prevention
资金
- MenAfriNet consortium
- Bill & Melinda Gates Foundation [OPP1084298]
The introduction and rollout of a meningococcal serogroup A conjugate vaccine, MenAfriVac, in the African meningitis belt has eliminated serogroup A meningococcal infections for >300 million Africans. However, serogroup C, W, and X meningococci continue to circulate and have been responsible for focal epidemics in meningitis belt countries. Affordable multivalent meningococcal conjugate vaccines are being developed to prevent these non-A epidemics. This article describes the current epidemiologic situation and status of vaccine development and highlights questions to be addressed to most efficiently use these new vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据